Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α

STATs and Gene Regulation

Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979 · see citing works

INTERFERONS AND THEIR ACTIONS

Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,826 · see citing works

TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway

Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808 · see citing works

Chronic Myeloid Leukemia

Sawyers, C. L. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401706 · Cited by 1,615 · see citing works

Prognostic discrimination in "good-risk" chronic granulocytic leukemia

Sokal, J., Cox, E. B., Baccarani, M., Tura, S., Gomez, G., Je, R., Tso, C. Y., Braun, T., Clarkson, B., & Cervantes, F. (1984) · Blood · doi:10.1182/blood.v63.4.789.bloodjournal634789 · Cited by 1,208 · see citing works

Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene

Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · see citing works

Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia

The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301204 · Cited by 571 · see citing works

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

Guilhot, F., Chastang, C., Michallet, M., Guerci‐Bresler, A., Harousseau, J., Maloisel, F., Bouabdallah, R., Guyotat, D., Cheron, N., Nicolini, F. E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707243370402 · Cited by 536 · see citing works

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group [see comments]

Hehlmann, R., Heimpel, H., Hasford, J., Kolb, H., Pralle, H., Hossfeld, D., Queißer, W., Löffler, H., Hochhaus, A., & Heinze, B. (1994) · Blood · doi:10.1182/blood.v84.12.4064.bloodjournal84124064 · Cited by 445 · see citing works

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

Allan, N. C., Shepherd, P. C. A., & Richards, S. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92596-1 · Cited by 406 · see citing works

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.

Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · see citing works

Chronic Granulocytic Leukemia

Canellos, G. P. (1976) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31845-4 · Cited by 343 · see citing works

Bcr-Abl Efficiently Induces a Myeloproliferative Disease and Production of Excess Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor in Mice: A Novel Model for Chronic Myelogenous Leukemia

Zhang, X., & Ren, R. (1998) · Blood · doi:10.1182/blood.v92.10.3829 · Cited by 276 · see citing works

Highly Sensitive and Specific Fluorescence Reverse Transcription-PCR Assay for the Pseudogene-free Detection of β-Actin Transcripts as Quantitative Reference

Kreuzer, K., Laß, U., Landt, O., Nitsche, A., Laser, J., Ellerbrok, H., Pauli, G., Huhn, D., & Schmidt, C. A. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.2.297 · Cited by 199 · see citing works

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199 · see citing works

Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

Kantarjian, H. M., O'Brien, S. M., Anderlini, P. N., & Talpaz, M. (1996) · Blood · doi:10.1182/blood.v87.8.3069.bloodjournal8783069 · Cited by 177 · see citing works

Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.

Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74081-2 · Cited by 152 · see citing works

Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder

Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · see citing works

Different Real-Time PCR Formats Compared for the Quantitative Detection of Human Cytomegalovirus DNA

Nitsche, A., Steuer, N., Schmidt, C. A., Landt, O., & Siegert, W. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.11.1932 · Cited by 128 · see citing works

Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation

Nelson, N., Kanno, Y., Hong, C., Contursi, C., Fujita, T., Fowlkes, B. J., O’Connell, E., Hu-Li, J., Paul, W. E., Jankovic, D., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3711 · Cited by 110 · see citing works

Cytokine Gene Regulation: Regulatory cis-Elements and DNA Binding Factors Involved in the Interferon System

Tanaka, N., & Taniguchi, T. (1992) · Advances in immunology · doi:10.1016/s0065-2776(08)60877-9 · Cited by 89 · see citing works

Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukaemia

Hochhaus, A., Yan, X., Willer, A., Hehlmann, R., Gordon, M. Y., Goldman, J. M., & Melo, J. (1997) · Leukemia · doi:10.1038/sj.leu.2400723 · Cited by 46 · see citing works

The IRF Family Transcription Factors in Immunity and Oncogenesis

Tamura, T., Yanai, H., Savitsky, D., & Taniguchi, T. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090400 · Cited by 1,259 · see citing works

Regulation of immunity and oncogenesis by the IRF transcription factor family

Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298 · see citing works

The IRF family of transcription factors: Inception, impact and implications in oncogenesis

Yanai, H., Negishi, H., & Taniguchi, T. (2012) · OncoImmunology · doi:10.4161/onci.22475 · Cited by 261 · see citing works

Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein

Lee, C. H., Melchers, M., Wang, H., Torrey, T. A., Slota, R., Qi, C., Kim, J. Y., Lugar, P., Kong, H. J., Farrington, L. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051450 · Cited by 186 · see citing works

Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells

Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183 · see citing works

AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency

Schwieger, M., Löhler, J., Friel, J., Scheller, M., Horak, I. D., & Stocking, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020824 · Cited by 142 · see citing works

Regulation of myelopoiesis by the transcription factor IRF8

Tamura, T., Kurotaki, D., & Koizumi, S.-I. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1761-9 · Cited by 139 · see citing works

Interferon-α, but not the ABL-kinase inhibitor imatinib (STI571), induces expression of myeloblastin and a specific T-cell response in chronic myeloid leukemia

Burchert, A., Wölfl, S., Schmidt, M., Brendel, C. A., Denecke, B., Cai, D., Odyvanova, L., Lahaye, T., Müller, M. C., Berg, T., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0659 · Cited by 132 · see citing works

Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages

Tamura, T., Thotakura, P., Tanaka, T. S., Ko, M. S. H., & Ozato, K. (2005) · Blood · doi:10.1182/blood-2005-01-0080 · Cited by 133 · see citing works

Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia

Will, B., Vogler, T. O., Narayanagari, S., Bartholdy, B., Todorova, T. I., da Silva Ferreira, M., Chen, J., Yu, Y., Mayer, J., Barreyro, L., et al. (2015) · Nature Medicine · doi:10.1038/nm.3936 · Cited by 127 · see citing works

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

Baccarani, M., Martinelli, G., Rosti, G., Trabacchi, E., Testoni, N., Bassi, S., Amabile, M., Soverini, S., Castagnetti, F., Cilloni, D., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0826 · Cited by 105 · see citing works

Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2

Burchert, A. (2003) · Blood · doi:10.1182/blood-2003-08-2970 · Cited by 102 · see citing works

Shared and Distinct Functions of the Transcription Factors IRF4 and IRF8 in Myeloid Cell Development

Yamamoto, M., Kato, T., Hotta, C., Nishiyama, A., Kurotaki, D., Yoshinari, M., Takami, M., Ichino, M., Nakazawa, M., Matsuyama, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025812 · Cited by 94 · see citing works

IFN Consensus Sequence Binding Protein/IFN Regulatory Factor-8 Guides Bone Marrow Progenitor Cells Toward the Macrophage Lineage

Tsujimura, H., Nagamura‐Inoue, T., Tamura, T., & Ozato, K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1261 · Cited by 82 · see citing works

The interferon-alpha revival in CML

Talpaz, M., Mercer, J., & Hehlmann, R. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2326-y · Cited by 61 · see citing works

ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells

Tamura, T., Kong, H. J., Tunyaplin, C., Tsujimura, H., Calame, K. L., & Ozato, K. (2003) · Blood · doi:10.1182/blood-2003-01-0291 · Cited by 61 · see citing works

IRF-4 functions as a tumor suppressor in early B-cell development

Acquaviva, J., Chen, X., & Ren, R. (2008) · Blood · doi:10.1182/blood-2007-10-117838 · Cited by 59 · see citing works

Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1

Liu, J., & Ma, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602059200 · Cited by 56 · see citing works

The Interferon Consensus Sequence-binding Protein (ICSBP/IRF8) Represses PTPN13 Gene Transcription in Differentiating Myeloid Cells

Huang, W., Zhu, C., Wang, H., Horvath, E., & Eklund, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706710200 · Cited by 54 · see citing works

The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15Ink4b in murine myeloid cells

Schmidt, M., Bies, J., Tamura, T., Ozato, K., & Wolff, L. (2004) · Blood · doi:10.1182/blood-2003-01-0285 · Cited by 58 · see citing works

Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia

Konieczna, I. M., Horvath, E., Wang, H., Lindsey, S. C., Saberwal, G. S., Bei, L., Huang, W., Platanias, L. C., & Eklund, E. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33742 · Cited by 53 · see citing works

Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance

Scheller, M., Schönheit, J., Zimmermann, K., Leser, U., Rosenbauer, F., & Leutz, A. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130706 · Cited by 48 · see citing works

How I determine if and when to recommend stopping tyrosine kinase inhibitor treatment for chronic myeloid leukaemia

Ross, D. M., & Hughes, T. P. (2014) · British Journal of Haematology · doi:10.1111/bjh.12892 · Cited by 48 · see citing works

The response to imatinib and interferon- is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

Palandri, F., Castagnetti, F., Iacobucci, I., Martinelli, G., Amabile, M., Gugliotta, G., Poerio, A., Testoni, N., Breccia, M., Bocchia, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.021246 · Cited by 45 · see citing works

Interferon Consensus Sequence Binding Protein (ICSBP) Decreases β-Catenin Activity in Myeloid Cells by Repressing GAS2 Transcription

Huang, W., Zhou, W. J., Saberwal, G. S., Konieczna, I., Horvath, E., Katsoulidis, E., Platanias, L. C., & Eklund, E. A. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-09 · Cited by 45 · see citing works

Interferon Regulatory Factor-8 Is Indispensable for the Expression of Promyelocytic Leukemia and the Formation of Nuclear Bodies in Myeloid Cells

Dror, N., Rave-Harel, N., Burchert, A., Azriel, A., Tamura, T., Tailor, P. B., Neubauer, A., Ozato, K., & Levi, B.-Z. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607825200 · Cited by 44 · see citing works

The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model

Ren, R. (2002) · Oncogene · doi:10.1038/sj.onc.1206090 · Cited by 43 · see citing works

Interferon-alfa for chronic myeloid leukemia

Baccarani, M., Russo, D., Rosti, G., & Martinelli, G. (2003) · Seminars in Hematology · doi:10.1016/s0037-1963(03)70040-7 · Cited by 42 · see citing works

MMP3-Mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction

Banik, D., Netherby, C. S., Bogner, P. N., & Abrams, S. I. (2015) · Oncotarget · doi:10.18632/oncotarget.3897 · Cited by 41 · see citing works

Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region

Ortmann, C. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1001 · Cited by 40 · see citing works

Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis

Jo, S., Schatz, J. H., Acquaviva, J., Singh, H., & Ren, R. (2010) · Blood · doi:10.1182/blood-2009-07-234559 · Cited by 37 · see citing works

Low expression of interferon regulatory factor‐1 and identification of novel exons skipping in patients with chronic myeloid leukaemia

Tzoanopoulos, D., Speletas, M. G., Arvanitidis, K. I., Veiopoulou, C., Kyriaki, S., Thyphronitis, G., Sideras, P., Kartalis, G., & Ritis, K. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03829.x · Cited by 38 · see citing works

Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker

Martı́nez, A., Pittaluga, S., Rudelius, M., DAVIES-HILL, T. M., Sebasigari, D., Fountaine, T. J., Hewitt, S. M., Jaffe, E. S., & Raffeld, M. A. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318166f46a · Cited by 38 · see citing works

Interferon regulatory factors: A key to tumour immunity

Chen, Y., Li, J., Lü, N., & Shen, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.010 · Cited by 34 · see citing works

Interferon a and T-cell responses in chronic myeloid leukemia

Burchert, A., & Neubauer, A. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400012029 · Cited by 33 · see citing works

Implication of IRF4 Aberrant Gene Expression in the Acute Leukemias of Childhood

Adamaki, M., Lambrou, G., Athanasiadou, A., Tzanoudaki, M., Vlahopoulos, S., & Moschovi, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072326 · Cited by 22 · see citing works

Regulation of the Interferon regulatory factor-8 (IRF-8) Tumor Suppressor Gene by the Signal Transducer and Activator of Transcription 5 (STAT5) Transcription Factor in Chronic Myeloid Leukemia

Waight, J. D., Banik, D., Griffiths, E. A., Nemeth, M. J., & Abrams, S. I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544320 · Cited by 29 · see citing works

IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation

Massimino, M., Consoli, M. L., Mesuraca, M., Stagno, F., Tirrò, E., Stella, S., Pennisi, M. S., Romano, C., Buffa, P., Bond, H. M., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu013 · Cited by 27 · see citing works

Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia

Brümmendorf, T. H., Ersöz, I., Hartmann, U., Balabanov, S., Wolke, H., Paschka, P., Lahaye, T., Berner, B., Bartolović, K., Kreil, S., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03229.x · Cited by 27 · see citing works

Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling

Sharma, A. K., Yun, H., Jyotsana, N., Chaturvedi, A., Schwarzer, A., Yung, E., Lai, C. K., Kuchenbauer, F. C., Argiropoulos, B., Görlich, K., et al. (2014) · Leukemia · doi:10.1038/leu.2014.162 · Cited by 26 · see citing works

Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells

Stirewalt, D. L., Choi, Y. E., Sharpless, N. E., Pogosova‐Agadjanyan, E. L., Cronk, M. R., Yukawa, M., Larson, E. B., Wood, B. L., Appelbaum, F. R., Radich, J. P., et al. (2008) · Leukemia · doi:10.1038/leu.2008.176 · Cited by 28 · see citing works

Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34‐positive cells and its down‐regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia

Ito, K., Tanaka, H., Ito, T., Sultana, T. A., Kyo, T., Imanaka, F., Ohmoto, Y., & Kimura, A. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00275.x · Cited by 26 · see citing works

High Affinity Molecules Disrupting GRB2 Protein Complexes as a Therapeutic Strategy for Chronic Myelogenous Leukaemia

Feller, S. M., Tuchscherer, G., & Voss, J. H. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000037930 · Cited by 25 · see citing works

Relevance of Interferon Regulatory Factor-8 Expression in Myeloid–Tumor Interactions

Abrams, S. I., Netherby, C. S., Twum, D. Y. F., & Messmer, M. N. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0174 · Cited by 24 · see citing works

Interferon in chronic myeloid leukaemia: past and future

Guilhot, F., Roy, L., Saulnier, P., & Guilhot, J. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.10.005 · Cited by 21 · see citing works

Loss of a Negative Feedback Loop between IRF8 and AR Promotes Prostate Cancer Growth and Enzalutamide Resistance

Wu, H., You, L., Li, Y., Zhao, Z., Shi, G., Chen, Z., Wang, Z., Li, X., Du, S., Ye, W., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2549 · Cited by 19 · see citing works

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia

Pogosova‐Agadjanyan, E. L., Kopecky, K. J., Ostronoff, F., Appelbaum, F. R., Godwin, J. E., Lee, H., List, A. F., May, J. J., Oehler, V. G., Petersdorf, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070812 · Cited by 20 · see citing works

The Interferon Consensus Sequence Binding Protein (ICSBP/IRF8) Activates Transcription of the FANCF Gene during Myeloid Differentiation

Saberwal, G. S., Horvath, E., Hu, L., Zhu, C., Hjort, E. E., & Eklund, E. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010231 · Cited by 19 · see citing works

A multi-functional role of interferon regulatory factor-8 in solid tumor and myeloid cell biology

Abrams, S. I. (2009) · Immunologic Research · doi:10.1007/s12026-009-8125-6 · Cited by 17 · see citing works

Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias

Koenigsmann, J., Rudolph, C., Sander, S., Kershaw, O., Gruber, A. D., Bullinger, L., Schlegelberger, B., & Carstanjen, D. (2009) · Blood · doi:10.1182/blood-2008-05-158485 · Cited by 17 · see citing works

The Transcription Factor IRF8 Counteracts BCR-ABL to Rescue Dendritic Cell Development in Chronic Myelogenous Leukemia

Watanabe, T., Hotta, C., Koizumi, S.-I., Miyashita, K., Nakabayashi, J., Kurotaki, D., Sato, G. R., Yamamoto, M., Nakazawa, M., Fujita, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0802 · Cited by 15 · see citing works

Fas-associated phosphatase 1 mediates Fas resistance in myeloid progenitor cells expressing the Bcr–abl oncogene

Huang, W., Bei, L., & Eklund, E. A. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.720979 · Cited by 15 · see citing works

Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia

Gurevich, R. M., Rosten, P., Schwieger, M., Stocking, C., & Humphries, R. K. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.04.020 · Cited by 15 · see citing works

BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia

Leo, E., Mancini, M., Aluigi, M., Luatti, S., Castagnetti, F., Testoni, N., Soverini, S., Santucci, M. A., & Martinelli, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081425 · Cited by 14 · see citing works

Interfering with leukemic stem cells

Krause, D. S., & Etten, R. A. V. (2008) · Nature Medicine · doi:10.1038/nm0508-494 · Cited by 12 · see citing works

IRF-4 Suppresses BCR/ABL Transformation of Myeloid Cells in a DNA Binding-independent Manner

Jo, S., & Ren, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289728 · Cited by 11 · see citing works

Immunotherapeutic approaches in chronic myelogenous leukemia

Guilhot, F., Roy, L., Saulnier, P., Guilhot, J., Barra, A., Gombert, J., & Turhan, A. G. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190801927510 · Cited by 11 · see citing works

The Roles of IRF-8 in Regulating IL-9-Mediated Immunologic Mechanisms in the Development of DLBCL: A State-of-the-Art Literature Review

Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 10 · see citing works

Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells

Hara, T., Schwieger, M., Kazama, R., Okamoto, S., Minehata, K., Ziegler, M., Löhler, J., & Stocking, C. (2008) · Oncogene · doi:10.1038/sj.onc.1211043 · Cited by 10 · see citing works

ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia

Otto, N., Manukjan, G., Göhring, G., Hofmann, W. A., Scherer, R., Luna, J., Lehmann, U., Ganser, A., Welte, K., Schlegelberger, B., et al. (2011) · Leukemia · doi:10.1038/leu.2011.61 · Cited by 9 · see citing works

The Leukemia-associated Fusion Protein Tel-Platelet-derived Growth Factor Receptor β (Tel-PdgfRβ) Inhibits Transcriptional Repression of PTPN13 Gene by Interferon Consensus Sequence Binding Protein (Icsbp)

Huang, W., Hu, L., Bei, L., Hjort, E. E., & Eklund, E. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.294884 · Cited by 9 · see citing works

Immunotherapy in Chronic Myelogenous Leukemia

Guilhot, F., Roy, L., Martineau, G., Guilhot, J., & Millot, F. (2007) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2007.s.004 · Cited by 9 · see citing works

Altered IFNγ Signaling and Preserved Susceptibility to Activated Natural Killer Cell–Mediated Lysis of BCR/ABL Targets

Cebo, C., Voutsadakis, I. A., Rocha, S. D., Bourhis, J.-H., Jalil, A., Azzarone, B. G., Turhan, A. G., Chelbi‐Alix, M. K., Chouaı̈b, S., & Caignard, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1932 · Cited by 8 · see citing works

IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia

Huang, X., Ma, T., Zhu, Y., Jiao, B., Yu, S., Wang, K., Mi, J., & Ren, R. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0858-1 · Cited by 7 · see citing works

Transcriptional Regulation of Emergency Granulopoiesis in Leukemia

Hasan, S., Naqvi, A. R., & Rizvi, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00481 · Cited by 6 · see citing works

BCR-ABL as a target for novel therapeutic interventions

Kindler, T., Meyer, R., & Fischer, T. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.1.85 · Cited by 4 · see citing works

Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation

Zhu, C., Lindsey, S. C., Konieczna, I., & Eklund, E. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0807514 · Cited by 4 · see citing works

MafK Mediates Chromatin Remodeling to Silence IRF8 Expression in Non-immune Cells in a Cell Type-SpecificManner

Fourier, N., Zolty, M., Azriel, A., Tedesco, D., & Levi, B.-Z. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.06.005 · Cited by 3 · see citing works

The Interferon Alpha Revival in CML

Talpaz, M., Mercer, J., & Hehlmann, R. (2016) · Hematologic malignancies · doi:10.1007/978-3-319-33198-0_14 · Cited by 2 · see citing works

Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

Chelysheva, E., Gurianova, M. A., & Turkina, A. (2021) · Clinical oncohematology · doi:10.21320/2500-2139-2021-14-4-427-435 · Cited by 1 · see citing works

Gene expression changes in normal haematopoietic cells

Lionberger, J. M., & Stirewalt, D. L. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.05.005 · Cited by 1 · see citing works

Ph positive-leukemias

Guilhot, F., Roy, L., Guilhot, J., Saulnier, P. J., Gombert, J., & Turhan, A. G. (2009) · Hematology Meeting Reports (formerly Haematologica Reports) · doi:10.4081/hmr.v2i5.720

Aberrant Transcription Factors in AML

Friedman, A. D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_2

Chronic myeloid leukemia and allogeneic natural killer cells: a surprising dialogue

Wittnebel, S., Bourhis, J.-H., & Caignard, A. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.627

Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes

Lehtonen, A. (2005) · Työväentutkimus Vuosikirja

The Interferon-Alpha Revival in CML

Talpaz, M., Mercer, J., & Hehlmann, R. (2021) · Hematologic malignancies · doi:10.1007/978-3-030-71913-5_13

Molekulare Grundlagen der malignen Transformation

Neubauer, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-54676-1_186-1

Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias

Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199 · see citing works

Expression of interferon consensus sequence binding protein induces potent immunity against BCR/ABL-induced leukemia

Deng, M., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.11.3491 · Cited by 50 · see citing works

Expression of Interferon Consensus Sequence Binding Protein (ICSBP) Is Downregulated in Bcr-Abl-Induced Murine Chronic Myelogenous Leukemia-Like Disease, and Forced Coexpression of ICSBP Inhibits Bcr-Abl-Induced Myeloproliferative Disorder

Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · see citing works

The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha.

Román‐Gómez, J., Jiménez‐Velasco, A., Castillejo, J. A., Cervantes, F., Barrios, M., Colomer, D., Heiniger, A., & Torres, A. (2004) · PubMed · Cited by 57 · see citing works

A Possible Correlation between Interferon-stimulated Gene Expression and Cytogenetic Responses in Chronic Myelogenous Leukemia Patients Treated with -interferon

Kawakubo, K., Ohyashiki, K., Ohyashiki, J. H., Shimamoto, T., Fujimura, T., Iwama, H., & Toyama, K. (1996) · Japanese Journal of Clinical Oncology · doi:10.1093/oxfordjournals.jjco.a023185 · Cited by 3 · see citing works